Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: ChemMedChem. 2014 May 6;9(6):1150–1153. doi: 10.1002/cmdc.201402074

Table 1.

IC50 values [μM] of cisplatin and conjugates 1 and 2, as determined in proliferation assays for different tumor cell lines with incubation times of 24 h and 72 h.

HCT 116[a] OVCAR3[b] MDA-MB-231[c] 1483 HNSCC[d]
24 h 72 h 24 h 72 h 24 h 72 h 24 h 72 h
cisplatin 22.3 12.0 10.7 2.07 159.8 20.0 8.6 2.0
1 2.5 1.1 7.7 2.2 20.1 1.65 3.5 0.69
2 0.22 0.065 1.5 0.13 1.05 0.05 0.54 0.045
[a]

Colorectal carcinoma, no COX-2 expression.

[b]

Ovarian adenocarcinoma, COX-1 expression.

[c]

Breast adenocarcinoma, COX-2 expression.

[d]

Head and neck squamous cell carcinoma, high COX-2 expression.